Quidel (QDEL) and Ortho Announce Expected Closing of Ortho Transaction May 26, 2022 12:26PM
Quidel and Ortho Announce Expected Closing of Ortho Transaction May 26, 2022 12:24PM
Quidel and Ortho Announce Expected Closing of Ortho Transaction May 26, 2022 12:05PM
Ortho Clinical Diagnostics Shareholders Approve Quidel Transaction May 16, 2022 04:45PM
Ortho Clinical Diagnostics Reports First Quarter 2022 Results May 4, 2022 04:05PM


Apr 26, 2022 08:59AM Ortho Clinical Diagnostics Recognized with Fifth Prestigious Edison Award for Highly Accurate COVID-19 Solution
Apr 20, 2022 04:14PM Ortho Clinical Diagnostics to Report First Quarter 2022 Results on May 4, 2022
Mar 9, 2022 08:55AM Ortho Clinical Diagnostics Wins Bronze Stevie® Award for Customer Service and Support
Feb 16, 2022 04:05PM Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2021 Results
Jan 6, 2022 04:52PM Ortho Clinical Diagnostics (OCDX) Reports Prelim Q4 Results
Jan 6, 2022 04:50PM Ortho Clinical Diagnostics Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2021
Jan 3, 2022 08:00AM Ortho Clinical Diagnostics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Dec 23, 2021 07:01AM Quidel Corp (QDEL) to Acquire Ortho Clinical Diagnostics (OCDX) in $6 Billion Deal
Dec 23, 2021 07:00AM Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
Nov 23, 2021 08:00AM Ortho Clinical Diagnostics to Participate in the 4th Annual Evercore ISI HealthCONx Conference
Nov 3, 2021 04:05PM Ortho Clinical Diagnostics Reports Third Quarter 2021 Results
Oct 12, 2021 04:15PM Ortho Clinical Diagnostics to Report Third Quarter 2021 Results on November 3, 2021
Sep 27, 2021 10:00AM Ortho Customers Rank Company No. 1 in Service and Support for Sixth Consecutive Year
Sep 27, 2021 08:00AM Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities
Sep 3, 2021 09:00AM Ortho Clinical Diagnostics to Participate in September Investor Conferences
Aug 5, 2021 09:12AM Ortho Clinical Diagnostics (OCDX) Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocapsid Antibody Test
Aug 5, 2021 09:05AM Ortho Clinical Diagnostics Expands COVID-19 Test Offerings with Emergency Use Authorization (EUA) of Total Nucleocapsid Antibody Test
Aug 4, 2021 04:05PM Ortho Clinical Diagnostics Reports Second Quarter 2021 Results
Jul 26, 2021 09:00AM ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in Canada
Jul 23, 2021 09:00AM Ortho Clinical Diagnostics to Report Second Quarter 2021 Results on August 4, 2021
Jul 22, 2021 09:00AM Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack, Latest Addition to Ortho's Critical Care Blood Testing Menu
Jul 7, 2021 09:00AM Ortho Clinical Diagnostics Announces Partnership With Thermo Fisher Scientific
Jun 7, 2021 09:00AM ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico
May 20, 2021 07:30PM Ortho Clinical Diagnostics to Present at Upcoming Investor Conferences
May 5, 2021 04:30PM Ortho Clinical Diagnostics Reports First Quarter 2021 Results
May 3, 2021 08:00AM Global Transfusion Medicine Leader Ortho Clinical Diagnostics Launches Next Gen ORTHO VISION® Swift Platform
Apr 26, 2021 12:57PM Ortho Clinical Diagnostics Recognized With Prestigious Edison Award for Highly Accurate COVID-19 Solutions Capable of Mass-Scale Testing
Apr 21, 2021 09:00AM Ortho Clinical Diagnostics to Report First Quarter 2021 Results on May 5, 2021
Apr 13, 2021 08:45AM Ortho Clinical Diagnostics (OCDX) VITROS SARS-CoV-2 Antigen Test for High-Volume COVID-19 Testing Receives CE Mark
Apr 13, 2021 08:44AM Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume COVID-19 Testing Receives CE Mark; Allows for More Convenient Sample Collection and Expanded Viral Transport Media
Mar 31, 2021 07:45PM Ortho Announces Plans to Accelerate COVID-19 Antigen and Antibody Test Development Through New Contract with BARDA and the Department of Defense
Mar 23, 2021 08:06AM Ortho's (OCDX) VITROS SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data
Mar 23, 2021 08:00AM Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data
Mar 18, 2021 08:33PM REPLACING: Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2020 Results
Mar 18, 2021 04:05PM Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year 2020 Results
Mar 8, 2021 08:20AM Ortho's (OCDX) New COVID-19 Total and IgG Antibody Tests Receive CE Mark for Semi-Quantitative Results
Mar 8, 2021 08:00AM Ortho's New COVID-19 Total and IgG Antibody Tests Receive CE Mark for Semi-Quantitative Results
Mar 4, 2021 08:00AM Ortho Clinical Diagnostics to Report Fourth Quarter and Full Year 2020 Results on March 18, 2021
Feb 23, 2021 04:15PM Ortho Clinical Diagnostics Names Evelyn Dilsaver to Board of Directors
Feb 9, 2021 04:05PM Ortho Clinical Diagnostics Amends Credit Agreement to Extend Maturity and Increase Borrowing Capacity Under its Revolving Credit Facility